- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Serum Institute, CII to work together for expansion of COVID vaccination in small towns, rural areas
"Our partnership with CII will be a good way to close the gaps, as there is plenty of supply of Covishield available for distribution," Poonawalla said.
New Delhi: Industry chamber CII on Friday said it has entered into an agreement with Serum Institute of India (SII) to accelerate COVID vaccination in small towns and rural areas.
The chamber said the partnership with Serum Institute will help catalyze industry participation to reach out to communities at large.
"Overall, industry has been playing a responsible part in ensuring vaccination of workers and their families, but clearly given the scale and urgency of the vaccination program, we can complement and supplement the efforts of the government in this pivotal mission for the nation," CII President T V Narendran said in a statement.
On the development, Serum Institute of India CEO Adar Poonawalla said it is essential that all stakeholders work together towards carrying out the inoculations.
"Our partnership with CII will be a good way to close the gaps, as there is plenty of supply of Covishield available for distribution," Poonawalla said.
As part of the pan-India vaccine demand aggregation exercise, CII undertook a survey with response from over 3,000 companies in 196 cities.
Read also: Serum Institute to begin Sputnik V production in September
"This identified a requirement of over 7 million single dose vaccines. As of July 23, 2021, a total of 34,75,301 (3.4 million) single doses have been administered through 430 camps held across the country by the CII and the CII Foundation," it added.
To further scale up the efforts, CII said it is now mapping the vaccination need requirement state-wise and setting up vaccination camps along with its members focusing on reaching Tier 2/3 cities and rural areas.
Read also: Serum Institute gets expert panel nod to phase 2, 3 trial of Covovax for 2-17 years old
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751